Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.
This report aims to provide a comprehensive presentation of the global market for Recombinant Coagulation Factors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Coagulation Factors. This report contains market size and forecasts of Recombinant Coagulation Factors in global, including the following market information:
Global Recombinant Coagulation Factors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Recombinant Coagulation Factors market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Recombinant Factor VIII Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Coagulation Factors include Baxter International Inc., Bayer AG, Biogen Idec, CSL Ltd., Grifols International SA, Kedrion S.P.A., Novo Nordisk A/S, Octapharma AG and Pfizer Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Coagulation Factors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Coagulation Factors Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Recombinant Coagulation Factors Market Segment Percentages, by Type, 2022 (%)
Recombinant Factor VIII
Recombinant Factor IX
Von Willebrand Factor
Global Recombinant Coagulation Factors Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Recombinant Coagulation Factors Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Research Organizations
Global Recombinant Coagulation Factors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Recombinant Coagulation Factors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Coagulation Factors revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Recombinant Coagulation Factors revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter International Inc.
Bayer AG
Biogen Idec
CSL Ltd.
Grifols International SA
Kedrion S.P.A.
Novo Nordisk A/S
Octapharma AG
Pfizer Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Coagulation Factors, market overview.
Chapter 2: Global Recombinant Coagulation Factors market size in revenue.
Chapter 3: Detailed analysis of Recombinant Coagulation Factors company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Coagulation Factors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Coagulation Factors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Coagulation Factors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Coagulation Factors Overall Market Size
2.1 Global Recombinant Coagulation Factors Market Size: 2022 VS 2029
2.2 Global Recombinant Coagulation Factors Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Coagulation Factors Players in Global Market
3.2 Top Global Recombinant Coagulation Factors Companies Ranked by Revenue
3.3 Global Recombinant Coagulation Factors Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Coagulation Factors Companies in Global Market, by Revenue in 2022
3.5 Global Companies Recombinant Coagulation Factors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Coagulation Factors Players in Global Market
3.6.1 List of Global Tier 1 Recombinant Coagulation Factors Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant Coagulation Factors Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Coagulation Factors Market Size Markets, 2022 & 2029
4.1.2 Recombinant Factor VIII
4.1.3 Recombinant Factor IX
4.1.4 Von Willebrand Factor
4.2 By Type - Global Recombinant Coagulation Factors Revenue & Forecasts
4.2.1 By Type - Global Recombinant Coagulation Factors Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Coagulation Factors Revenue, 2024-2029
4.2.3 By Type - Global Recombinant Coagulation Factors Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Coagulation Factors Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Organizations
5.2 By Application - Global Recombinant Coagulation Factors Revenue & Forecasts
5.2.1 By Application - Global Recombinant Coagulation Factors Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Coagulation Factors Revenue, 2024-2029
5.2.3 By Application - Global Recombinant Coagulation Factors Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Recombinant Coagulation Factors Market Size, 2022 & 2029
6.2 By Region - Global Recombinant Coagulation Factors Revenue & Forecasts
6.2.1 By Region - Global Recombinant Coagulation Factors Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Coagulation Factors Revenue, 2024-2029
6.2.3 By Region - Global Recombinant Coagulation Factors Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Recombinant Coagulation Factors Revenue, 2018-2029
6.3.2 US Recombinant Coagulation Factors Market Size, 2018-2029
6.3.3 Canada Recombinant Coagulation Factors Market Size, 2018-2029
6.3.4 Mexico Recombinant Coagulation Factors Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Recombinant Coagulation Factors Revenue, 2018-2029
6.4.2 Germany Recombinant Coagulation Factors Market Size, 2018-2029
6.4.3 France Recombinant Coagulation Factors Market Size, 2018-2029
6.4.4 U.K. Recombinant Coagulation Factors Market Size, 2018-2029
6.4.5 Italy Recombinant Coagulation Factors Market Size, 2018-2029
6.4.6 Russia Recombinant Coagulation Factors Market Size, 2018-2029
6.4.7 Nordic Countries Recombinant Coagulation Factors Market Size, 2018-2029
6.4.8 Benelux Recombinant Coagulation Factors Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Recombinant Coagulation Factors Revenue, 2018-2029
6.5.2 China Recombinant Coagulation Factors Market Size, 2018-2029
6.5.3 Japan Recombinant Coagulation Factors Market Size, 2018-2029
6.5.4 South Korea Recombinant Coagulation Factors Market Size, 2018-2029
6.5.5 Southeast Asia Recombinant Coagulation Factors Market Size, 2018-2029
6.5.6 India Recombinant Coagulation Factors Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Recombinant Coagulation Factors Revenue, 2018-2029
6.6.2 Brazil Recombinant Coagulation Factors Market Size, 2018-2029
6.6.3 Argentina Recombinant Coagulation Factors Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Recombinant Coagulation Factors Revenue, 2018-2029
6.7.2 Turkey Recombinant Coagulation Factors Market Size, 2018-2029
6.7.3 Israel Recombinant Coagulation Factors Market Size, 2018-2029
6.7.4 Saudi Arabia Recombinant Coagulation Factors Market Size, 2018-2029
6.7.5 UAE Recombinant Coagulation Factors Market Size, 2018-2029
7 Recombinant Coagulation Factors Companies Profiles
7.1 Baxter International Inc.
7.1.1 Baxter International Inc. Company Summary
7.1.2 Baxter International Inc. Business Overview
7.1.3 Baxter International Inc. Recombinant Coagulation Factors Major Product Offerings
7.1.4 Baxter International Inc. Recombinant Coagulation Factors Revenue in Global Market (2018-2023)
7.1.5 Baxter International Inc. Key News & Latest Developments
7.2 Bayer AG
7.2.1 Bayer AG Company Summary
7.2.2 Bayer AG Business Overview
7.2.3 Bayer AG Recombinant Coagulation Factors Major Product Offerings
7.2.4 Bayer AG Recombinant Coagulation Factors Revenue in Global Market (2018-2023)
7.2.5 Bayer AG Key News & Latest Developments
7.3 Biogen Idec
7.3.1 Biogen Idec Company Summary
7.3.2 Biogen Idec Business Overview
7.3.3 Biogen Idec Recombinant Coagulation Factors Major Product Offerings
7.3.4 Biogen Idec Recombinant Coagulation Factors Revenue in Global Market (2018-2023)
7.3.5 Biogen Idec Key News & Latest Developments
7.4 CSL Ltd.
7.4.1 CSL Ltd. Company Summary
7.4.2 CSL Ltd. Business Overview
7.4.3 CSL Ltd. Recombinant Coagulation Factors Major Product Offerings
7.4.4 CSL Ltd. Recombinant Coagulation Factors Revenue in Global Market (2018-2023)
7.4.5 CSL Ltd. Key News & Latest Developments
7.5 Grifols International SA
7.5.1 Grifols International SA Company Summary
7.5.2 Grifols International SA Business Overview
7.5.3 Grifols International SA Recombinant Coagulation Factors Major Product Offerings
7.5.4 Grifols International SA Recombinant Coagulation Factors Revenue in Global Market (2018-2023)
7.5.5 Grifols International SA Key News & Latest Developments
7.6 Kedrion S.P.A.
7.6.1 Kedrion S.P.A. Company Summary
7.6.2 Kedrion S.P.A. Business Overview
7.6.3 Kedrion S.P.A. Recombinant Coagulation Factors Major Product Offerings
7.6.4 Kedrion S.P.A. Recombinant Coagulation Factors Revenue in Global Market (2018-2023)
7.6.5 Kedrion S.P.A. Key News & Latest Developments
7.7 Novo Nordisk A/S
7.7.1 Novo Nordisk A/S Company Summary
7.7.2 Novo Nordisk A/S Business Overview
7.7.3 Novo Nordisk A/S Recombinant Coagulation Factors Major Product Offerings
7.7.4 Novo Nordisk A/S Recombinant Coagulation Factors Revenue in Global Market (2018-2023)
7.7.5 Novo Nordisk A/S Key News & Latest Developments
7.8 Octapharma AG
7.8.1 Octapharma AG Company Summary
7.8.2 Octapharma AG Business Overview
7.8.3 Octapharma AG Recombinant Coagulation Factors Major Product Offerings
7.8.4 Octapharma AG Recombinant Coagulation Factors Revenue in Global Market (2018-2023)
7.8.5 Octapharma AG Key News & Latest Developments
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Recombinant Coagulation Factors Major Product Offerings
7.9.4 Pfizer Inc. Recombinant Coagulation Factors Revenue in Global Market (2018-2023)
7.9.5 Pfizer Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Recombinant Coagulation Factors Market Opportunities & Trends in Global Market
Table 2. Recombinant Coagulation Factors Market Drivers in Global Market
Table 3. Recombinant Coagulation Factors Market Restraints in Global Market
Table 4. Key Players of Recombinant Coagulation Factors in Global Market
Table 5. Top Recombinant Coagulation Factors Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Recombinant Coagulation Factors Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Recombinant Coagulation Factors Revenue Share by Companies, 2018-2023
Table 8. Global Companies Recombinant Coagulation Factors Product Type
Table 9. List of Global Tier 1 Recombinant Coagulation Factors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Coagulation Factors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Coagulation Factors Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Recombinant Coagulation Factors Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Recombinant Coagulation Factors Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Recombinant Coagulation Factors Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Recombinant Coagulation Factors Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Recombinant Coagulation Factors Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Recombinant Coagulation Factors Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Recombinant Coagulation Factors Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Recombinant Coagulation Factors Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Recombinant Coagulation Factors Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Recombinant Coagulation Factors Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Recombinant Coagulation Factors Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Recombinant Coagulation Factors Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Recombinant Coagulation Factors Revenue, (US$, Mn), 2024-2029
Table 30. Baxter International Inc. Company Summary
Table 31. Baxter International Inc. Recombinant Coagulation Factors Product Offerings
Table 32. Baxter International Inc. Recombinant Coagulation Factors Revenue (US$, Mn) & (2018-2023)
Table 33. Baxter International Inc. Key News & Latest Developments
Table 34. Bayer AG Company Summary
Table 35. Bayer AG Recombinant Coagulation Factors Product Offerings
Table 36. Bayer AG Recombinant Coagulation Factors Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer AG Key News & Latest Developments
Table 38. Biogen Idec Company Summary
Table 39. Biogen Idec Recombinant Coagulation Factors Product Offerings
Table 40. Biogen Idec Recombinant Coagulation Factors Revenue (US$, Mn) & (2018-2023)
Table 41. Biogen Idec Key News & Latest Developments
Table 42. CSL Ltd. Company Summary
Table 43. CSL Ltd. Recombinant Coagulation Factors Product Offerings
Table 44. CSL Ltd. Recombinant Coagulation Factors Revenue (US$, Mn) & (2018-2023)
Table 45. CSL Ltd. Key News & Latest Developments
Table 46. Grifols International SA Company Summary
Table 47. Grifols International SA Recombinant Coagulation Factors Product Offerings
Table 48. Grifols International SA Recombinant Coagulation Factors Revenue (US$, Mn) & (2018-2023)
Table 49. Grifols International SA Key News & Latest Developments
Table 50. Kedrion S.P.A. Company Summary
Table 51. Kedrion S.P.A. Recombinant Coagulation Factors Product Offerings
Table 52. Kedrion S.P.A. Recombinant Coagulation Factors Revenue (US$, Mn) & (2018-2023)
Table 53. Kedrion S.P.A. Key News & Latest Developments
Table 54. Novo Nordisk A/S Company Summary
Table 55. Novo Nordisk A/S Recombinant Coagulation Factors Product Offerings
Table 56. Novo Nordisk A/S Recombinant Coagulation Factors Revenue (US$, Mn) & (2018-2023)
Table 57. Novo Nordisk A/S Key News & Latest Developments
Table 58. Octapharma AG Company Summary
Table 59. Octapharma AG Recombinant Coagulation Factors Product Offerings
Table 60. Octapharma AG Recombinant Coagulation Factors Revenue (US$, Mn) & (2018-2023)
Table 61. Octapharma AG Key News & Latest Developments
Table 62. Pfizer Inc. Company Summary
Table 63. Pfizer Inc. Recombinant Coagulation Factors Product Offerings
Table 64. Pfizer Inc. Recombinant Coagulation Factors Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Inc. Key News & Latest Developments
List of Figures
Figure 1. Recombinant Coagulation Factors Segment by Type in 2022
Figure 2. Recombinant Coagulation Factors Segment by Application in 2022
Figure 3. Global Recombinant Coagulation Factors Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Coagulation Factors Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Coagulation Factors Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Coagulation Factors Revenue in 2022
Figure 8. By Type - Global Recombinant Coagulation Factors Revenue Market Share, 2018-2029
Figure 9. By Application - Global Recombinant Coagulation Factors Revenue Market Share, 2018-2029
Figure 10. By Type - Global Recombinant Coagulation Factors Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Recombinant Coagulation Factors Revenue Market Share, 2018-2029
Figure 12. By Application - Global Recombinant Coagulation Factors Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Recombinant Coagulation Factors Revenue Market Share, 2018-2029
Figure 14. By Region - Global Recombinant Coagulation Factors Revenue Market Share, 2018-2029
Figure 15. By Country - North America Recombinant Coagulation Factors Revenue Market Share, 2018-2029
Figure 16. US Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Recombinant Coagulation Factors Revenue Market Share, 2018-2029
Figure 20. Germany Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 21. France Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Recombinant Coagulation Factors Revenue Market Share, 2018-2029
Figure 28. China Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 32. India Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Recombinant Coagulation Factors Revenue Market Share, 2018-2029
Figure 34. Brazil Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Recombinant Coagulation Factors Revenue Market Share, 2018-2029
Figure 37. Turkey Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Recombinant Coagulation Factors Revenue, (US$, Mn), 2018-2029
Figure 41. Baxter International Inc. Recombinant Coagulation Factors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer AG Recombinant Coagulation Factors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Biogen Idec Recombinant Coagulation Factors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. CSL Ltd. Recombinant Coagulation Factors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Grifols International SA Recombinant Coagulation Factors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Kedrion S.P.A. Recombinant Coagulation Factors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novo Nordisk A/S Recombinant Coagulation Factors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Octapharma AG Recombinant Coagulation Factors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Inc. Recombinant Coagulation Factors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
